These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 35728185)

  • 1. Simulating the impact of vaccination rates on the initial stages of a COVID-19 outbreak in Aotearoa New Zealand with a stochastic model.
    Watson LM
    N Z Med J; 2022 Apr; 135():66-76. PubMed ID: 35728185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.
    Watson LM
    N Z Med J; 2022 Apr; 135():89-100. PubMed ID: 35728188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study.
    Datta S; Vattiato G; Maclaren OJ; Hua N; Sporle A; Plank MJ
    Vaccine; 2024 Feb; 42(6):1383-1391. PubMed ID: 38307744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Effectiveness of Strategies for the Control of Equine Influenza Virus in the New Zealand Equine Population.
    Rosanowski SM; Cogger N; Rogers CW; Stevenson MA
    Transbound Emerg Dis; 2016 Jun; 63(3):321-32. PubMed ID: 25287746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A COVID-19 vaccination model for Aotearoa New Zealand.
    Steyn N; Plank MJ; Binny RN; Hendy SC; Lustig A; Ridings K
    Sci Rep; 2022 Feb; 12(1):2720. PubMed ID: 35177804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting willingness to be vaccinated for Covid-19: Evidence from New Zealand.
    Kaine G; Wright V; Greenhalgh S
    PLoS One; 2022; 17(4):e0266485. PubMed ID: 35390053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand.
    Jelley L; Douglas J; Ren X; Winter D; McNeill A; Huang S; French N; Welch D; Hadfield J; de Ligt J; Geoghegan JL
    Nat Commun; 2022 Jul; 13(1):4035. PubMed ID: 35821124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations into a trigger-based approach for initiating emergency vaccination to augment stamping out of foot-and-mouth disease in New Zealand: a simulation study.
    Sanson RL; Yu ZD; Rawdon TG; van Andel M
    N Z Vet J; 2021 Nov; 69(6):313-326. PubMed ID: 33886430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study.
    Vilches TN; Abdollahi E; Cipriano LE; Haworth-Brockman M; Keynan Y; Sheffield H; Langley JM; Moghadas SM
    BMC Public Health; 2022 May; 22(1):1042. PubMed ID: 35614429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination and testing of the border workforce for COVID-19 and risk of community outbreaks: a modelling study.
    Plank MJ; Binny RN; Hendy SC; Lustig A; Ridings K
    R Soc Open Sci; 2021 Sep; 8(9):210686. PubMed ID: 34631122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the benefits of vaccination when used in combination with stamping-out measures against hypothetical introductions of foot-and-mouth disease into New Zealand: a simulation study.
    Sanson RL; Rawdon T; Owen K; Hickey K; van Andel M; Yu ZD
    N Z Vet J; 2017 May; 65(3):124-133. PubMed ID: 27870922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine breakthrough infections in a highly-vaccinated Australian population during a SARS-CoV-2 Delta outbreak.
    Sheel M; Vun Voo T; Pingault N; Sloan-Gardner TS; Marmor A; Kirk MD; Johnston V; Coleman K
    Commun Dis Intell (2018); 2022 Jun; 46():. PubMed ID: 35739073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the impact of control measures to prevent outbreaks of COVID-19 associated with air travel into a COVID-19-free country.
    Wilson N; Baker MG; Blakely T; Eichner M
    Sci Rep; 2021 May; 11(1):10766. PubMed ID: 34031465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downsizing of COVID-19 contact tracing in highly immune populations.
    Martignoni MM; Renault J; Baafi J; Hurford A
    PLoS One; 2022; 17(6):e0268586. PubMed ID: 35687566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued mitigation needed to minimise the high health burden from COVID-19 in Aotearoa New Zealand.
    Baker MG; Kvalsvig A; Plank MJ; Geoghegan JL; Wall T; Tukuitonga C; Summers J; Bennett J; Kerr J; Turner N; Roberts S; Ward K; Betty B; Huang QS; French N; Wilson N
    N Z Med J; 2023 Oct; 136(1583):67-91. PubMed ID: 37797257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
    Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain.
    AlQahtani M; Du X; Bhattacharyya S; Alawadi A; Al Mahmeed H; Al Sayed J; Justman J; El-Sadr WM; Hidary J; Mukherjee S
    Sci Rep; 2022 Jun; 12(1):9236. PubMed ID: 35654940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time estimation of the effective reproduction number of SARS-CoV-2 in Aotearoa New Zealand.
    Binny RN; Lustig A; Hendy SC; Maclaren OJ; Ridings KM; Vattiato G; Plank MJ
    PeerJ; 2022; 10():e14119. PubMed ID: 36275456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.